Raj Manchanda

Dr. Raj Manchanda is currently Innovation Portfolio Leader at Bill and Melinda Gates Medical Research Institute (Gates MRI) in Cambridge. Raj holds a Ph. D in Chemistry from Yale University, an M.Sc. in Chemistry from the Indian Institute of Technology, and a B.Sc. in Chemistry from Delhi University. He was also an Anna Fuller postdoctoral fellow at MIT. Previously he was at Frequency Therapeutics where he was Chief Development Officer. Prior to Frequency, Raj was VP of Neurodegeneration and Early-Stage Therapeutics at Biogen. He also held leadership positions at Diatide, Avid Radiopharmaceuticals, Perkin Elmer Life and Analytical Sciences, and URL Pharmaceuticals.